Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-60
SponsorKasr El Aini Hospital

About this trial

This study aims to evaluate the effects of Mediterranean and Paleolithic dietary interventions on nutritional status, disease activity, fatigue, sleep, and quality of life in adults with rheumatoid arthritis (RA). Participants aged 40-60 years will be randomly assigned to follow either a Mediterranean diet, a Paleolithic diet, or continue their usual diet for 12 weeks. The study will assess anthropometric measurements, disease activity score (DAS28), laboratory biomarkers (CBC, CRP, ESR, lipid profile, fasting glucose, HbA1c), and patient-reported outcomes. The trial will determine whether these diets improve RA management and overall well-being.

Eligibility criteria

Qualifiers

Patients classified as having rheumatoid arthritis according to the 2010 rheumatoid arthritis ACR/ EULAR classification criteria with a selected age group of 40 to 60 years old.

Disqualifiers

Patients with comorbidities (e.g., diabetes mellitus, hypertension, gout, thyroid dysfunction).

Trial design

Treatments tested in this trial

  • Mediterranean Diet (MD)
  • Paleolithic Diet (PD)
  • Control (Usual Diet)

Treatment groups

75 Participants
are divided into 3 treatment groups

Sponsors and collaborators